Yoshiaki Iwasaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yoshiaki Iwasaki has a total of 200 co-authors. Here are the top co-authors by number of shared publications:
- Kazuhide Yamamoto
Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
19 shared publications - Fusao Ikeda
Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
14 shared publications - Kazuhiro Nouso
Department of Gastroenterology, Okayama City Hospital, Okayama, Japan
12 shared publications Akinobu Takaki
9 shared publicationsAkio Moriya
9 shared publications- Hideaki Taniguchi
Department of Medicine and Medical Science (Medicine I), Okayama University Graduate School of Medicine and Dentistry
8 shared publications
Latest Publications
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S1084-S1085
HBSAG Levels Decrease with Age in Chronic Hepatitis B: A Hospital-Based Longitudinal Study
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S1084-S1085
HBSAG Levels Decrease with Age in Chronic Hepatitis B: A Hospital-Based Longitudinal Study
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S238
Roles of Metabolic Syndrome-Related Factors in Gastroesophageal Reflux Disease: A Longitudinal Study
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S238
Roles of Metabolic Syndrome-Related Factors in Gastroesophageal Reflux Disease: A Longitudinal Study
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S1146
Mo1563 Roles of Fatty Liver in Glucose Intolerance and Dyslipidemia: A Longitudinal Study
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S1146
Mo1563 Roles of Fatty Liver in Glucose Intolerance and Dyslipidemia: A Longitudinal Study
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S674
Mo1233 Effect of Helicobacter pylori Eradication on Glucose and Lipid Metabolism in a General Population: A Longitudinal Study
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S674
Mo1233 Effect of Helicobacter pylori Eradication on Glucose and Lipid Metabolism in a General Population: A Longitudinal Study
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S674-S675
Mo1234 Effect of Helicobacter pylori Eradication on Anemia, Inflammation, and Nutritional Status in a General Population: A Longitudinal Study
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S674-S675
Mo1234 Effect of Helicobacter pylori Eradication on Anemia, Inflammation, and Nutritional Status in a General Population: A Longitudinal Study
- Open Access
Association between Knowledge about Comprehensive Food Education and Increase in Dental Caries in Japanese University Students: A Prospective Cohort Study
In Japan, comprehensive food education (shokuiku) programs are carried out with the aim of improving dietary practices and thereby reducing the incidence of lifestyle-related diseases, including dental caries. The purpose of this prospective cohort study was to investigate the association between knowledge about shokuiku and the increase in dental caries among Japanese university students who had attended a shokuiku program while in junior/senior high school. A total of 562 students volunteered to undergo oral examinations over a three-year follow-up period, during which the number of cases of dental caries were recorded. Additional information was collected using a questionnaire survey regarding knowledge about shokuiku, dietary habits, and oral health behaviors. In logistic regression analysis, males who lacked knowledge about shokuiku had significantly higher odds for dental caries than those who did not (odds ratio (OR), 2.00; 95% confidence interval (CI), 1.12–3.58; p = 0.019). On the other hand, among females, those who frequently consumed sugar-sweetened soft drinks had significantly higher odds for dental caries than those who did not (OR, 1.89; 95% CI, 1.05–3.42; p = 0.035). These results suggest that having no knowledge about shokuiku is associated with a risk of increase in dental caries in Japanese male university students.
Open AccessAssociation between Knowledge about Comprehensive Food Education and Increase in Dental Caries in Japanese University Students: A Prospective Cohort Study
In Japan, comprehensive food education (shokuiku) programs are carried out with the aim of improving dietary practices and thereby reducing the incidence of lifestyle-related diseases, including dental caries. The purpose of this prospective cohort study was to investigate the association between knowledge about shokuiku and the increase in dental caries among Japanese university students who had attended a shokuiku program while in junior/senior high school. A total of 562 students volunteered to undergo oral examinations over a three-year follow-up period, during which the number of cases of dental caries were recorded. Additional information was collected using a questionnaire survey regarding knowledge about shokuiku, dietary habits, and oral health behaviors. In logistic regression analysis, males who lacked knowledge about shokuiku had significantly higher odds for dental caries than those who did not (odds ratio (OR), 2.00; 95% confidence interval (CI), 1.12–3.58; p = 0.019). On the other hand, among females, those who frequently consumed sugar-sweetened soft drinks had significantly higher odds for dental caries than those who did not (OR, 1.89; 95% CI, 1.05–3.42; p = 0.035). These results suggest that having no knowledge about shokuiku is associated with a risk of increase in dental caries in Japanese male university students.
- 1 April 2015
- Published by Elsevier in Journal of Hepatology
- Vol. 62 (4) , 921-927
Roles of alcohol consumption in fatty liver: A longitudinal study
- 1 April 2015
- Published by Elsevier in Journal of Hepatology
- Vol. 62 (4) , 921-927
Roles of alcohol consumption in fatty liver: A longitudinal study
- Open Access
- 21 February 2015
- Published by Elsevier in Journal of Hepatology
- Vol. 62 (5) , 1211-1212
Reply to: “Protective effects of moderate alcohol consumption on fatty liver: A spurious association?”
- 21 February 2015
- Published by Elsevier in Journal of Hepatology
- Vol. 62 (5) , 1211-1212
Open AccessReply to: “Protective effects of moderate alcohol consumption on fatty liver: A spurious association?”
- 1 January 2015
- Vol. 69 (3) , 137-44
Aberrant Expression of Keratin 7 in Hepatocytes as a Predictive Marker of Rapid Progression to Hepatic Failure in Asymptomatic Primary Biliary Cirrhosis.
A predictive marker of the rapid progression to hepatic failure is desired for patients with asymptomatic primary biliary cirrhosis (aPBC). We performed a systematic cohort analysis of 101 patients diagnosed as having aPBC and the rapid progression to liver failure in some, by focusing on cholestasis. Cholestasis was assessed by aberrant keratin7 (K-7) expressions in the patients' hepatocytes. Intralobular expressions of K-7 were found in 9 of the 101 patients. The grades of K-7 expression were significantly associated with the levels of alanine aminotransferase, alkaline phosphatase, and total bilirubin at the time of diagnosis, but not with bile duct loss or cholestasis. Stepwise logistic regression analysis revealed that high grades of K-7 expression correlated positively with high levels of total bilirubin. During the follow-up period, 8 patients developed jaundice, and the mean period until the development of jaundice was 5.2 years. The proportional hazards models for the risk of developing jaundice identified a high grade of aberrant K-7 expression in hepatocytes as the only significant risk factor. Aberrant K-7 expression in hepatocytes can be used as an additional marker to predict rapid progression to liver failure in patients with aPBC at the time of diagnosis.
- 1 January 2015
- Vol. 69 (3) , 137-44
Aberrant Expression of Keratin 7 in Hepatocytes as a Predictive Marker of Rapid Progression to Hepatic Failure in Asymptomatic Primary Biliary Cirrhosis.
A predictive marker of the rapid progression to hepatic failure is desired for patients with asymptomatic primary biliary cirrhosis (aPBC). We performed a systematic cohort analysis of 101 patients diagnosed as having aPBC and the rapid progression to liver failure in some, by focusing on cholestasis. Cholestasis was assessed by aberrant keratin7 (K-7) expressions in the patients' hepatocytes. Intralobular expressions of K-7 were found in 9 of the 101 patients. The grades of K-7 expression were significantly associated with the levels of alanine aminotransferase, alkaline phosphatase, and total bilirubin at the time of diagnosis, but not with bile duct loss or cholestasis. Stepwise logistic regression analysis revealed that high grades of K-7 expression correlated positively with high levels of total bilirubin. During the follow-up period, 8 patients developed jaundice, and the mean period until the development of jaundice was 5.2 years. The proportional hazards models for the risk of developing jaundice identified a high grade of aberrant K-7 expression in hepatocytes as the only significant risk factor. Aberrant K-7 expression in hepatocytes can be used as an additional marker to predict rapid progression to liver failure in patients with aPBC at the time of diagnosis.
- 1 January 2015
- Vol. 69 (4) , 237-44
Effectiveness of extending treatment duration in therapy with pegylated interferon and ribavirin for genotype 2 hepatitis C virus infection.
The effectiveness of extending treatment duration as response guided therapy was previously reported for chronic hepatitis C (CHC) genotype 1, but is still controversial for genotype 2. The present study is a retrospective cohort study to investigate the effectiveness of extending treatment duration in therapy with pegylated interferon and ribavirin for patients with CHC genotype 2 by focusing on the timing at which patients obtained undetectable HCV RNA. A total of 306 patients who obtained undetectable HCV RNA by week 24 of treatment and completed 24 weeks of treatment were enrolled. Rapid virological response (RVR) to standard therapy was achieved by 122 patients (51%), and 89% of them obtained sustained virological response (SVR), while 69% of non-RVR patients achieved SVR. Non-RVR patients with undetectable HCV RNA at week 8, and insufficient adherence<80% pegylated interferon and ribavirin during the first 24 weeks, significantly improved their SVR rate by extended therapy. Among patients receiving extended therapy, drug adherences did not differ between SVR and non-SVR patients, indicating that extending treatment duration might compensate for insufficient antiviral effects due to insufficient drug adherences. This finding might be useful in creating a guideline for extending treatment duration for patients with CHC genotype 2.
- 1 January 2015
- Vol. 69 (4) , 237-44
Effectiveness of extending treatment duration in therapy with pegylated interferon and ribavirin for genotype 2 hepatitis C virus infection.
The effectiveness of extending treatment duration as response guided therapy was previously reported for chronic hepatitis C (CHC) genotype 1, but is still controversial for genotype 2. The present study is a retrospective cohort study to investigate the effectiveness of extending treatment duration in therapy with pegylated interferon and ribavirin for patients with CHC genotype 2 by focusing on the timing at which patients obtained undetectable HCV RNA. A total of 306 patients who obtained undetectable HCV RNA by week 24 of treatment and completed 24 weeks of treatment were enrolled. Rapid virological response (RVR) to standard therapy was achieved by 122 patients (51%), and 89% of them obtained sustained virological response (SVR), while 69% of non-RVR patients achieved SVR. Non-RVR patients with undetectable HCV RNA at week 8, and insufficient adherence<80% pegylated interferon and ribavirin during the first 24 weeks, significantly improved their SVR rate by extended therapy. Among patients receiving extended therapy, drug adherences did not differ between SVR and non-SVR patients, indicating that extending treatment duration might compensate for insufficient antiviral effects due to insufficient drug adherences. This finding might be useful in creating a guideline for extending treatment duration for patients with CHC genotype 2.